JAKARTA (TheInsiderStories) – President Joko Widodo received his second injection of CoronaVac today after get the firs shoot two weeks ago. The vaccine produced by Chinese drug-maker, Sinovac Life Science Co. Ltd., and state-owned firm, PT Bio Farma.
The CoronaVac has secured an emergency use permit from the Food and Drug Administration after going through a number of clinical trials involving 1,620 volunteers in Bandung. The Indonesian Ulema Council has also stated that the vaccine is holy and lawful so that it can be used for the vaccination program in Indonesia.
Like the other drugs, the vaccine required two injection doses for each recipient to strengthen the immune response from the first dose of injection. A total of 0.5 milliliter doses of vaccine are injected to each people.
After get the injection, Widodo said that the government targeted the vaccination program to be carried out for one million people a day based on the number of vaccinators and hospitals. He admitted that the vaccination process needs an improvement in the field. The delayed of vaccine distribution, he noted, has caused health workers have received the new vaccine only reached 250,000 people.
“This is the target. But it does take time, it requires good field management and this is what I always convey to the minister of health,” he told the media at his office.
End of last year, the minister of health, Budi Gunadi Sadikin, explained Indonesia needs around 426 million doses to fulfill ‘herd immunity” for around 181 million people. To reached the targets, he said, the government has ensured to meet the number of vaccine producers.
Currently, he said, the government has signed a contract for 125 million doses of vaccine from Sinovac with an additional option to 100 million doses of vaccines and 130 million total doses of vaccine from US’ Novavax.
In addition, the government will also sign a contract with AstraZeneca to obtain up to 100 million doses of vaccine and another 100 million other doses which will also be imported from BioNTech-Pfizer. Sadikin stated, a 50-million-dose deal with AstraZeneca would be finalized before end of 2020, and the same size with Pfizer in the first week of January.
“Obtaining vaccines from these four sources aims to ensure the resilience or security of vaccines coming to Indonesia in the quantities needed. The very large number of COVID-19 vaccines is expected to come to Indonesia soon,” he asserted.
In total, said Sadikin, Indonesia will receive 660 million doses of vaccine including from CEVI and GAVI, a public – private global health partnership. In the press conference held today, he also reported, that the vaccination program will be given free of charge to all citizens.
Earlier, the head of state has instructed all levels in the cabinet, ministries, agencies and local governments to prioritize the vaccination program in the 2021 fiscal year. He also instructed and ordered the minister of finance to prioritize and reallocates other budget related to the availability and vaccination for free.
The CEO of state-owned drug maker, PT Bio Farma, Honesti Basyir, said Indonesian government need funds around Rp68 trillion (US$4.85 billion) to produces vaccines in 2021. The assumption based on the vaccine price of Rp200,000 a dose.
In addition, said Basyir, the subsidiary, PT Kimia Farma Tbk (IDX: KAEF), is also waiting for the results of cooperation with a company from Abu Dhabi, G42, to procure vaccines in Indonesia.
Written by Editorial Staff, Email: firstname.lastname@example.org